<DOC>
	<DOCNO>NCT01382498</DOCNO>
	<brief_summary>Diabetic retinopathy ( DR ) highly specific vascular complication type 1 type 2 diabetes mellitus . Calcium dobesilate ( CD ) Doxium test treatment diabetic retinopathy show slowdown progression disease long-term oral treatment , potent antioxidant . Endothelin-1 ( ET-1 ) Besides potent vasoconstrictor , act mitogen vascular smooth muscle play main role failure autoregulation important often early feature diabetic retinopathy.several study confirm inflammation besides oxidative stress main mechanism , pathogenesis DR hsCRP play sensitive role detect inflammation patient . The aim study determine effect CD decrease ET-1 hsCRP serum level patient diabetic retinopathy .</brief_summary>
	<brief_title>Effect Doxium High Sensitivity CRP Endothelin-1 Serum Levels Patients With Diabetic Retinopathy</brief_title>
	<detailed_description />
	<mesh_term>Retinal Diseases</mesh_term>
	<mesh_term>Diabetic Retinopathy</mesh_term>
	<mesh_term>Calcium , Dietary</mesh_term>
	<mesh_term>Calcium Dobesilate</mesh_term>
	<criteria>BS 120200 mg/dl Age 4070 Severe NPDR ( non proliferative diabetic retinopathy ) PDR ( proliferative diabetic retinopathy ) type II diabetes history doxium consumption Allergy doxium incidence active hepatic disease rise hepatic enzyme intervention</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>April 2011</verification_date>
	<keyword>Endothelin-1 high sensitivity CRP</keyword>
</DOC>